About AbbVie in Australia
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, in addition to products and services across its Allergan Aesthetics portfolio.
Senior Communications and Patient Relations Manager
+61 (0)479 188 228
1 SKYRIZI Approved Product Information – Available at: http://www.medicines.org.au/files/vepskyri.pdf. Accessed 4 May 2022.
2 Arthritis Australia. Psoriatic Arthritis. Available at: https://arthritisaustralia.com.au/wordpress/wp-content/uploads/2017/09/ArthAus_PsoriaticArthritis_1805.pdf. Accessed May 2022.
3 Duarte GV, et al. Psoriatic arthritis. Best Pract Res Clin Rheumatol. 2012 Feb;26(1):147-56. doi:10.1016/j.berh.2012.01.003.
4 Psoriatic Arthritis American College of Rheumatology (v1.0)
5 Gladman D et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome.
6 MSK website: https://msk.org.au/psoriatic-arthritis/. Accessed May 2022.
7 Philip S Helliwell, Eric M Ruderman, Natural History, Prognosis, and Socioeconomic Aspects of Psoriatic Arthritis. 2015 Nov;41(4):581-91. doi: 10.1016/j.rdc.2015.07.004.
8 Gladman D. Recent advances in understanding and managing psoriatic arthritis. Version 1. F1000Res. 2016; 5: 2670.
9 Banerjee, S., et al. JAK–STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs 77.5 (2017): 521-546.
10 Hasan Tahir & Simran Grewal (2022) Current unmet needs and emerging novel pharmacotherapies in psoriatic arthritis, Expert Opinion on Pharmacotherapy, 23:4, 417-420, DOI: 10.1080/14656566.2021.2006184
11 Mahmood, F., et al. Current concepts and unmet needs in psoriatic arthritis. Clin Rheumatol. 2018 Feb;37(2):297-305. doi: 10.1007/s10067-017-3908-y. Epub 2017 Nov 13.
13 SKYRIZI Approved Consumer Medicines Information – Available at: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2019-CMI-01703-1